- The Wall Street Journal•5 hours ago
Fusion Pharmaceuticals Inc. has raised $25 million in a bid to build on the success of a new radio-pharmaceutical from Bayer AG that extends life for certain prostate cancer patients.
- Zacks•7 hours ago
Bayer AG's (BAYRY) fourth-quarter 2016 core earnings increased 10.2% year over year to ???1.19 per share (approximately $1.28). Reported earnings missed the Zacks Consensus Estimate of $1.37.
- The Wall Street Journal•16 hours ago
Bayer’s chief executive said he was confident the German firm’s planned $57 billion acquisition of Monsanto would overcome any regulatory obstacles and close by the end of the year, despite delays with ...
BAYN.DE : Summary for BAYER AG NA O.N. - Yahoo Finance
Bayer Aktiengesellschaft (BAYN.DE)
XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
|Bid||0.00 x 28400|
|Ask||0.00 x 2100|
|Day's Range||104.75 - 108.40|
|52 Week Range||83.45 - 112.00|
|PE Ratio (TTM)||18.53|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|